【摘要】 目的 :研究制备抗人喉癌 抗CD3 双功能抗体 ,探讨喉癌主动免疫治疗。方法 :以化学方法将人喉癌及抗CD3单克隆抗体交联为双功能抗体 ,进行介导对肿瘤细胞的杀伤作用。结果 :该双功能抗体介导效应细胞对靶细胞的杀伤率高于抗CD3 的介导作用 ,并随着效靶比的提高而升高。结论 :采用化学交联法制备的抗人喉癌 CD3 双功能抗体具有潜在的临床应用价值。更多还原

【Abstract】 Objective:To prepare bifunction antibody of anti-human laryngocarcinoma/anti-CD 3 for the active immune therapy of laryngocarcinoma.Methods:To corss link monoclonal antibody of anti-human laryngocarcinoma and anti-CD 3 into bifunction antibody by chemical method,which can guide the killer function on carcinoma cells.Results:The killer rate of effector cells guided by bifunction antibody is higher than that of anti-CD 3 which can arise with the elevation of effect target ratio.Conclusion:Bifunction antibody of anti-human laryngocarcinoma/anti-CD 3 prepared by chemical cross linking method has the potential value for clinical application. [更多还原